Physician profile

Roseann Milner

Adult Health (Nurse Practitioner) · West Babylon, NY

NPI 1932640950

$2,622.80

in general payments reported to CMS, 2019-2025

32 companies · $580 in 2025

The $580 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

See the full distribution for Adult Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,013.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $447.17 2023-2025 Jardiance
Merck Sharp & Dohme LLC $289.01 2021-2025 Verquvo, Belsomra, Steglatro
Novo Nordisk INC $196.83 2022-2025 Rybelsus, Ozempic, Wegovy
Daiichi Sankyo INC. $185.56 2021-2024 Injectafer
Exact Sciences Corporation $171.22 2023-2025 Cologuard Collection Kit
Lilly USA, LLC $167.46 2023-2024 Jardiance, Mounjaro, Zepbound
Amgen INC. $153.76 2022-2025 Evenity, Prolia, Repatha
Abbvie INC. $101.33 2024-2025
Mannkind Corporation $100.26 2021-2024 Afrezza
Pfizer INC. $96.85 2021-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $59.93 2021-2024 Lifevest
Xeris Pharmaceuticals, INC. $53.56 2022-2025 Gvoke Hypopen
Recordati_rare_diseases_inc. $49.88 2025 Isturisa
Amarin Pharma, INC. $47.37 2021
Boston Scientific Corporation $47.02 2025 Watchman Flx
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Bayer Healthcare Pharmaceuticals INC. $46.54 2024
Dexcom, INC. $41.52 2023 Dexcom G6 Transmitter
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $38.56 2021-2022
Astrazeneca Pharmaceuticals LP $37.17 2021
Novartis Pharmaceuticals Corporation $34.44 2024
Axsome Therapeutics, INC. $32.64 2025 Auvelity
Idorsia Pharmaceuticals US INC $28.24 2023 Quviviq
Radius Health, INC. $27.62 2024 Tymlos
Amneal Pharmaceuticals LLC $25.10 2025 Unithroid
Chiesi USA, INC. $21.80 2024 Mycapssa
Sanofi-Aventis U.S. LLC $20.82 2022
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $20.29 2022
Janssen Pharmaceuticals, INC $19.24 2023 Xarelto
Currax Pharmaceuticals LLC $17.59 2023 Contrave
Esperion Therapeutics, INC. $15.91 2025 Nexletol
Vistapharm, INC. $15.19 2021
Phadia US INC. $12.92 2023 Immunocap

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Roseann Milner

$2,622.80

in general payments reported 2019-2025

Years
2021-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $580 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

https://glasscript.com/doctor/10740376/roseann-milner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.